These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25101531)

  • 1. Antiretroviral therapy and the kidney.
    Wyatt CM
    Top Antivir Med; 2014; 22(3):655-8. PubMed ID: 25101531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney in HIV infection: beyond HIV-associated nephropathy.
    Wyatt CM
    Top Antivir Med; 2012; 20(3):106-10. PubMed ID: 22954611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.
    Wyatt CM; Klotman PE
    Expert Opin Drug Saf; 2006 Mar; 5(2):275-87. PubMed ID: 16503748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus infection and kidney disease.
    Hilton R
    J R Coll Physicians Edinb; 2013; 43(3):236-9; quiz 240. PubMed ID: 24087804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.
    Ryom L; Mocroft A; Kirk O; Ross M; Reiss P; Fux CA; Morlat P; Moranne O; Smith C; El-Sadr W; Law M; Lundgren JD
    AIDS; 2014 Jan; 28(2):187-99. PubMed ID: 24361680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury KDIGO stage 2 to 3 in HIV-positive patients treated with cART--a case series over 11 years in a cohort of 1,153 patients.
    Kurz M; Burkhalter F; Dickenmann M; Hopfer H; Mayr M; Elzi L; Battegay M
    Swiss Med Wkly; 2015; 145():w14135. PubMed ID: 26023828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Disease and HIV Infection.
    Wyatt CM
    Top Antivir Med; 2017; 25(1):13-16. PubMed ID: 28402929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.
    Berns JS; Kasbekar N
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):117-29. PubMed ID: 17699198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and renal disease: a contemporary review.
    Gameiro J; Jorge S; Lopes JA
    Int J STD AIDS; 2018 Jun; 29(7):714-719. PubMed ID: 29343165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.
    Fine DM; Perazella MA; Lucas GM; Atta MG
    Drugs; 2008; 68(7):963-80. PubMed ID: 18457462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral nephrotoxicities.
    Atta MG; Deray G; Lucas GM
    Semin Nephrol; 2008 Nov; 28(6):563-75. PubMed ID: 19013327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
    Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
    HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of chronic kidney disease in HIV-infected patients.
    Flandre P; Pugliese P; Cuzin L; Bagnis CI; Tack I; Cabié A; Poizot-Martin I; Katlama C; Brunet-François C; Yazdanpanah Y; Dellamonica P;
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1700-7. PubMed ID: 21566114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
    Stein JH
    Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.
    Jotwani V; Atta MG; Estrella MM
    J Am Soc Nephrol; 2017 Nov; 28(11):3142-3154. PubMed ID: 28784698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country.
    Santiago P; Grinsztejn B; Friedman RK; Cunha CB; Coelho LE; Luz PM; de Oliveira AV; Moreira RI; Cardoso SW; Veloso VG; Suassuna JH
    PLoS One; 2014; 9(4):e93748. PubMed ID: 24699873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational Agents.
    Gulick RM
    Top Antivir Med; 2015; 23(4):128-31. PubMed ID: 26713502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.
    Jabłonowska E; Wójcik K; Piekarska A
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):363-9. PubMed ID: 24164392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.